These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2103328)

  • 21. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.
    Yamazaki H; Guo Z; Guengerich FP
    Drug Metab Dispos; 1995 Mar; 23(3):438-40. PubMed ID: 7628313
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human hepatic alcohol dehydrogenase and human erythrocyte catalase do not metabolize the cytochrome P-4502E1 substrate, chlorzoxazone.
    McCarver-May DG; Durisin L
    Alcohol Clin Exp Res; 1996 May; 20(3):533-7. PubMed ID: 8727250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques.
    Tassaneeyakul W; Veronese ME; Birkett DJ; Gonzalez FJ; Miners JO
    Biochem Pharmacol; 1993 Dec; 46(11):1975-81. PubMed ID: 8267647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cytochrome P-450IIE1 in N-nitroso-N-methylaniline induced hepatocyte cytotoxicity.
    Quan Z; Khan S; O'Brien PJ
    Chem Biol Interact; 1992 Aug; 83(3):221-33. PubMed ID: 1516150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that cytochrome P450 2E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes.
    Amet Y; Berthou F; Goasduff T; Salaun JP; Le Breton L; Menez JF
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1168-74. PubMed ID: 8093035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.
    Kim RB; O'Shea D
    Clin Pharmacol Ther; 1995 Jun; 57(6):645-55. PubMed ID: 7781264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte cytotoxicity induced by various hepatotoxins mediated by cytochrome P-450IIE1: protection with diethyldithiocarbamate administration.
    Lauriault VV; Khan S; O'Brien PJ
    Chem Biol Interact; 1992 Feb; 81(3):271-89. PubMed ID: 1311644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.
    Kim RB; O'Shea D; Wilkinson GR
    Pharmacogenetics; 1994 Jun; 4(3):162-5. PubMed ID: 7920697
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
    Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
    Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    Shimada T; Tsumura F; Yamazaki H
    Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1.
    Lucas D; Menez JF; Berthou F
    Methods Enzymol; 1996; 272():115-23. PubMed ID: 8791768
    [No Abstract]   [Full Text] [Related]  

  • 36. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
    Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
    Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
    Gebhardt AC; Lucas D; Ménez JF; Seitz HK
    Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene.
    Speerschneider P; Dekant W
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlorzoxazone hydroxylation in microsomes and hepatocytes from cytochrome P450 oxidoreductase-null mice.
    Li L; Porter TD
    J Biochem Mol Toxicol; 2009; 23(5):357-63. PubMed ID: 19827131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.